StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$83.26−1.60 (-1.89%)

Close on Nov 18, 2026Market cap $20.92BP/E –Yield –

BioNTech shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 242M, up 0.5% from the year before. The highest annual figure on record is 260M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025242M+0.5%
FY2024Dec 31, 2024240M-0.9%
FY2023Dec 31, 2023243M-2.8%
FY2022Dec 31, 2022250M-3.8%
FY2021Dec 31, 2021260M+4.5%
FY2020Dec 31, 2020249M+17.5%
FY2019Dec 31, 2019212M+10.9%
FY2018Dec 31, 2018191M+14.4%
FY2017Dec 31, 2017167M–

More BioNTech figures

See a number that looks wrong?